SP100 and systemic lupus erythematosus: As expected, the level of AMA‐M2, anti‐gp210 and anti‐sp100 antibodies in PBC patients were higher than AIH patients, SLE patients (Other disease group, OD) and healthy controls (HC) (p < .01).